Novo Nordisk A S NVO
We take great care to ensure that the data presented and summarized in this overview for NOVO NORDISK A S is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NVO
View all-
Jennison Associates LLC21.1MShares$2.78 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.81 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.72 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.58 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.56 Billion4.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.8MShares$1.42 Billion2.18% of portfolio
-
Loomis Sayles & CO L P8.85MShares$1.17 Billion1.62% of portfolio
-
Folketrygdfondet8.76MShares$1.15 Billion25.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.59MShares$1.13 Billion0.14% of portfolio
-
Polen Capital Polen Capital Management LLC | Boca Raton, Fl7.77MShares$1.02 Billion2.3% of portfolio
Latest Institutional Activity in NVO
Top Purchases
Top Sells
About NVO
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Insider Transactions at NVO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|